Anti-ITGA4 & ITGB7重组抗体|科研级 Vedolizumab ( 维多组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-ITGA4 & ITGB7重组抗体|科研级 Vedolizumab ( 维多组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-ITGA4 & ITGB7重组抗体|科研级 Vedolizumab ( 维多组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1198

Alias

科研级 Vedolizumab ( 维多组单抗 ), Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Vedolizumab

Molecular Name

Vedolizumab

Size

1mg, 5mg

CAS Number

943609-66-3

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

146.81 kDa

Applications

FC, IP, ELISA, Neut, FuncS, IF

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6528H10072N1732O2042S42

Target

ITGA4_ITGB7[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ